HCW Biologics Company
HCW Biologics is developing immunotherapies to lengthen healthspan by disrupting the link between cellular senescence and disease.
Technology:
Geroscience
Industry:
Others
Headquarters:
United States
Founded Date:
2018-04-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
2
Total Funding:
$18.1M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series B
Register and Claim Ownership